Skip to content
DraconiticResearch
Search Sources API
182,544 studies31 sourcesUpdated 10 min ago
PreprintAll rights reservedbioRxiv

THERAPY RESISTANCE IN MELANOMA DRIVES CILIOGENESIS AND GLUTAMINE/ASPARTATE METABOLISM DEPENDENCY

  1. 1University of Padua

Related

  1. Targeting SLC1A5-mediated glutamine metabolism overcomes PARP inhibitor resistance in ovarian cancer.
    Fang Han, Hongjie Du, Kunlin Tian +4
    Cell death & diseasePeer-reviewedCC BYFull textOncologyEurope PMCDOAJ
  2. The glutamine-aspartate metabolic tradeoff between fast growth and metabolic flexibility
    Karin Ortmayr, Meret Ringwald, Laurentz Schuhknecht +8
    Genome BiologyPeer-reviewedCC BY 4.0OncologyCrossref
  3. Glutamine Metabolism in Cardiac Hypertrophy
    Zhi-Guo Hu, Yao Yao, Yan Gong +1
    Reviews in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  4. Aberrant Accumulation of Cyclin D1 Rewires Glutamine Metabolism and Generates a Metabolic Vulnerability in Squamous Cell Carcinoma
    Shuyuan Zhang, Polly J. Phillips-Mason, Bartosz Mucha +9
    Cancer researchPeer-reviewedLicence not statedFull textOncologyPMC
  5. ARHGAP40 suppresses clear cell renal cell carcinoma progression and is associated with altered glutamine-related metabolism and redox balance.
    Na You, Xiaoxia Wang, Caizhu Wang +7
    Cancer biology & therapyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@misc{lugato2026therapy,
  title = {{THERAPY RESISTANCE IN MELANOMA DRIVES CILIOGENESIS AND GLUTAMINE/ASPARTATE METABOLISM DEPENDENCY}},
  author = {P. Lugato and R. Castro and C. Thomas and S. Pedretti and R. Oberkersch and N. Mitro and M. M. Santoro},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.13.758838},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.13.758838v1},
}
RIS
TY  - UNPB
TI  - THERAPY RESISTANCE IN MELANOMA DRIVES CILIOGENESIS AND GLUTAMINE/ASPARTATE METABOLISM DEPENDENCY
AU  - P. Lugato
AU  - R. Castro
AU  - C. Thomas
AU  - S. Pedretti
AU  - R. Oberkersch
AU  - N. Mitro
AU  - M. M. Santoro
PY  - 2026
DA  - 2026/10/13
PB  - bioRxiv
DO  - 10.64898/2026.10.13.758838
UR  - https://www.biorxiv.org/content/10.64898/2026.10.13.758838v1
ER  -